Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TEVA Teva Pharmaceutical Industries Limited | ABBV AbbVie |
|---|---|---|
| Price | $38.98 -0.5% | $263.96 -0.0% |
| StockIQ Score | 67B- Moderate Risk: Medium | 59C Moderate Risk: High |
| Technical | 92A+ | 88A |
| Fundamental | 64C+ | 57C |
| Growth | 68B- | 34F |
| Fair Value | 50C- | 33F |
| News | 44D | 100A+ |
| Quality | 63C+ | 42D |
| Risk | 56C | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Teva Pharmaceutical has stronger investor and growth scores (67 vs. 59, 68 vs. 34), showing better investor confidence and potential for expansion. However, AbbVie leads in technical scoring (88 vs. 92—actually slightly lower, so Teva is technically stronger here too—but its fundamental score (57 vs. 64) and valuation (33 vs. 50) are weaker, indicating AbbVie may offer more stability and lower perceived risk.
